The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Thu., Mar. 28, 10:25 PM

Slide #4. Aeterna Zentaris Inc. Ceapro Inc.

Acquirer: Aeterna Zentaris Inc. (AEZS)
Acquiree: Ceapro Inc. (CRPOF)
Details: Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS.CA) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro") are pleased to announce that the Court of King's Bench of Alberta has issued a final order approving the arrangement described in the previously announced definitive agreement to combine the operations of Ceapro and Aeterna in an all-stock merger of equals transaction (the "Transaction").

Aeterna Zentaris is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s primary product, macimorelin, is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macimorelin is marketed in the U.S. under the tradename Macrilen™ through a license agreement with Novo Nordisk.

Open the AEZS Page at The Online Investor »

Aeterna Zentaris is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s primary product, macimorelin, is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macimorelin is marketed in the U.S. under the tradename Macrilen™ through a license agreement with Novo Nordisk.

Open the CRPOF Page at The Online Investor »

Company Name: 
AEterna Zentaris Inc
Website: 
www.zentaris.com
Sector: 
Drugs & Pharmaceuticals
Company Name: 
Ceapro Inc.
Website: 
www.ceapro.com
Sector: 
Specialty Chemicals
 

Quotes delayed 20 minutes

Email EnvelopeFree Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.